
Around 195,000 people globally will be treated for this form of lung cancer in 2026

The company has invested $40bn in US R&D and manufacturing in the past seven years

The study found significant reductions of major cardiovascular events in high-risk adults following treatment

The investment is expected to generate up to 750 new jobs

The phase 3 study included around 2,600 patients

Almost one million new cases of gastric cancer are diagnosed globally every year

The companies will focus on developing therapeutics across neuroscience, immunology and oncology

The company is the latest major drugmaker to announce a significant investment in the country

Immunoglobulin G4-related disease affects approximately 20,000 people in the US

The company is expecting to relocate its Cambridge-based employees to the new site in 2028

The funds will go towards a new global research and development centre in Beijing’s BioPark

Regulatory submissions are expected to be complete in the first half of this year